Tert-Butyl 2-Oxo-1,8-Diazaspiro[4.6]Undecane-8-Carboxylate
95%
- Product Code: 42490
CAS:
1251022-71-5
| Molecular Weight: | 268.35 g./mol | Molecular Formula: | C₁₄H₂₄N₂O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmaceutical agents. Its spirocyclic structure makes it valuable in the development of bioactive molecules, particularly those targeting neurological and psychiatric disorders. It is often employed in the design of inhibitors for enzymes or receptors involved in disease pathways. Additionally, its unique scaffold is explored in drug discovery programs to enhance the pharmacokinetic properties of potential drug candidates, such as improving stability and bioavailability. Researchers also leverage its chemical framework to create novel compounds for studying biological mechanisms and developing therapeutic interventions.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $1,879.39 |
+
-
|
| 0.250 | 10-20 days | $2,803.16 |
+
-
|
Tert-Butyl 2-Oxo-1,8-Diazaspiro[4.6]Undecane-8-Carboxylate
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmaceutical agents. Its spirocyclic structure makes it valuable in the development of bioactive molecules, particularly those targeting neurological and psychiatric disorders. It is often employed in the design of inhibitors for enzymes or receptors involved in disease pathways. Additionally, its unique scaffold is explored in drug discovery programs to enhance the pharmacokinetic properties of potential drug candidates, such as improving stability and bioavailability. Researchers also leverage its chemical framework to create novel compounds for studying biological mechanisms and developing therapeutic interventions.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :